SPAC
Should You Buy OHB Pediatrics Before the SPAC Merger Closes?
OHB Pediatrics Ltd. d/b/a Oak Hill Bio is a clinical-stage rare-disease therapeutics company going public through a merger with Research Alliance Corp III (Nasdaq: RACC). The deal is valued at about $160 million in base equity value, plus outstanding SAFEs and accrued interest, but the cash that actually reaches the company will depend on redemptions and committed financing.
Jul 29, 20266 MIN